What's New
Consultation – Proposed updates to the Guideline on the Regulation of Therapeutic Products in New Zealand: Clinical Trials
Medsafe is seeking feedback on:
- proposed updates to the Guideline on the Regulation of Therapeutic Products in New Zealand: Clinical trials
- new document: Considerations for First-In-Human (FIH) and Early Phase Clinical Trials
- new document: Clinical Trial Safety Monitoring and Reporting for Investigational Products (Medicines and Medical Devices).
The consultation closes on 27 October 2024
News and Events
| Date | Type | Title |
|---|---|---|
| 8/1/2025 | Notices | Notice of Medsafe Office Closure Christmas/New Year 2024/2025 |
| 16/10/2024 | Monitoring Communication |  Update - Calcium channel blockers and the possible risk of new-onset eczema |
| 8/10/2024 | Notices | Reclassification of Paracetamol Gazette Notice |
| 8/10/2024 | Notices | Reclassification of Naproxen Gazette Notice |
| 7/10/2024 | Notices | Updates to the Guidelines on the Regulation of Therapeutic Products in New Zealand: Requirements for information for prescribers and consumers |
| 30/9/2024 | Committees | Medicines Adverse Reactions Committee - vacancy for an epidemiologist/biostatistician |
| 11/9/2024 | Notices | Provisional consent granted for mpox vaccine |
| 5/9/2024 | Publications | Prescriber Update Vol. 45. No. 3 - September 2024 |
| 22/8/2024 | Consultation | Proposed updates to the Guideline on the Regulation of Therapeutic Products in New Zealand: Clinical Trials |
